FUS-依赖的微RNA放松调节将TRIB2确定为ALS运动神经元的可用药物标
Wan Yun Ho1,2, Li-Ling Chak1,3, Jin-Hui Hor4
1Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117549, Singapore.
iScience
|November 3, 2023
概括
研究人员研究了与FUS基因突变相关的肌缩性侧面硬化症 (ALS) 中的microRNA (miRNA) 变化. 他们发现,准促生存基因Trib2可能为ALS患者提供新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 微RNAs (miRNAs) 是基因表达的关键调节者,它们的失调与诸如肌缩性侧面硬化症 (ALS) 这样的疾病有关.
- 融合在肉瘤 (FUS) 基因是已知的ALS的因果因素,并影响miRNA的产生,使其成为一个关键的研究领域.
研究的目的:
- 系统地分析ALS-FUS小鼠中枢神经系统 (CNS) 中的miRNA表达特征.
- 阐明FUS依赖的miRNA放松调节在ALS病变发生中的作用.
- 为了确定ALS的潜在治疗点.
主要方法:
- 来自ALS-FUS小鼠的脊髓和海马组织的miRNA分析.
- 对不同中枢神经系统区域和疾病状态的miRNA表达的分析.
- 调查miR-1197和Trib2.2之间的目标关系.
- 评估患者衍生细胞中的Trib2表达和评估治疗干预措施.
主要成果:
- 在ALS-FUS小鼠中,在中枢神经系统区域和疾病状态之间确定了差异表达的miRNA.
- 发现miR-1197具有上调性,并向支持生存的基因Trib2.
- 从ALS患者的诱导多能干细胞 (iPSC) 衍生的运动神经元中观察到Trib2表达的减少.
- 在体外,Trib2蛋白的药理稳定拯救了运动神经元的存活率.
结论:
- 微RNA分析是了解ALS选择性脆弱性的分子机制的宝贵工具.
- 在ALS治疗中,Trib2是一个有前途的治疗标.
- 恢复Trib2功能可能为ALS提供一个可行的治疗策略,包括零星形式.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K


